Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Am J Emerg Med. 2021 Jun 29;49:343–351. doi: 10.1016/j.ajem.2021.06.049

Table 5.

Secondary outcomes in patients <21 years of age.

<21 and received capsaicin (n = 17) <21 and did not receive capsaicin (n = 8) p OR 95% CI
Secondary outcomes

Total ED length of stay (median) – hours 6 4.53 0.918
Total medications for symptom relief received – median, No. (range) 3 2 0.685
Admitted due to uncontrolled CHS symptoms – No. (%) 3 (17.6) 1 (12.5) 0.745 1.50 (0.131–17.180)
Return to ED in 24 h for same symptoms or complaint – No. (%) 0 0 0.724 0.49 (0.009–26.645)
Time to discharge or admission after administration of capsaicin or first agent (average) – hours 3.12 4.92 0.333
Change in pain score after administration of capsaicin or first agent – average (14 complete records) −0.22 −2.4 0.199